Leadership Changes - Teleflex Incorporated has appointed Stuart Randle as Interim President and CEO, succeeding Liam Kelly, who has stepped down from his roles [1] - Stephen Klasko has been appointed as Chairman of the Board [1][2] Revenue Outlook - The company has lowered its full-year revenue outlook for 2025 to a range of $3.270 billion to $3.278 billion, down from the previous guidance of $3.305 billion to $3.320 billion [3] - The revision is attributed to softer-than-expected demand for intra-aortic balloon pumps and catheters in the U.S. and Asia, delays in certain OEM purchase orders, and lower overall order volumes across parts of its portfolio [3] Strategic Focus - Teleflex is transitioning to a more focused, higher-growth organization following the announced sale of its Acute Care, Interventional Urology, and OEM businesses [3] - The Board believes this leadership transition is timely to best position the company for future growth [3]

Group 1 - The article does not provide any specific content related to a company or industry, as it appears to be a technical issue regarding browser settings and ad-blockers [1]